Statistics for Experience of daratumumab in relapsed/refractory multiple myeloma: A multicenter study from Turkiye

Total visits

views
Experience of daratumumab in relapsed/refractory multiple myeloma: A multicenter study from Turkiye 0

Total visits per month

views
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0